Roche Enter Obesity Market with Carmot Deal – European Pharmaceutical Manufacturer

Berkeley, California. Carmot’s R&D portfolio includes clinical stage subcutaneous and oral incretins with best-in-class potential to treat obesity …

Do you trust this headline?

Based on recent headline ratings, 82% of this readership currently trusts the local media, which has an average score of 81% regionally and is currently trending negative.

82%

Media Trust Score82%

In